Status:
COMPLETED
Prediction of Jaundice in Term Infants
Lead Sponsor:
NICHD Neonatal Research Network
Conditions:
Infant, Newborn
Jaundice
Eligibility:
All Genders
Up to 8 years
Brief Summary
The objective of this study was to describe total bilirubin production in healthy term infants as a means of understanding the differences in jaundice pigment production associated with various common...
Detailed Description
Jaundice occurs in most human neonates during the several days after birth. The objective of this study was to describe total bilirubin production in healthy term infants as a means of understanding t...
Eligibility Criteria
Inclusion
- Infants born via cesarean delivery (to ensure subjects would still be hospitalized and available for ETCOc measurement and blood sampling on day 3 postpartum)
- Delivery within each center's scheduled recruitment period (to maximize nursing availability and minimize cost)
- Birth weight \>2500 g
- Gestational age \>37 weeks
Exclusion
- Any illness that would require admission to the neonatal intensive-care unit (NICU) within 8 hours of birth
Key Trial Info
Start Date :
November 1 1991
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 1992
Estimated Enrollment :
535 Patients enrolled
Trial Details
Trial ID
NCT01203410
Start Date
November 1 1991
End Date
November 1 1992
Last Update
March 22 2019
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Palo Alto, California, United States, 94304
2
Yale University
New Haven, Connecticut, United States, 06504
3
George Washington University
Washington D.C., District of Columbia, United States, 20052
4
University of Miami
Miami, Florida, United States, 33136